The effects of food on the pharmacokinetics of a formulated ACP-103 tablet in healthy volunteers.
Vanover
Kimberly E
KE
ACADIA Pharmaceuticals, Inc, San Diego, CA, USA. kvanover@intracellulartherapies.com
Robbins-Weilert
Doris
D
Wilbraham
Darren G
DG
Mant
Timothy G K
TG
van Kammen
Daniel P
DP
Davis
Robert E
RE
Weiner
David M
DM
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D001682:Biological Availability; D018592:Cross-Over Studies; D005215:Fasting; D018565:Food-Drug Interactions; D006207:Half-Life; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D011618:Psychotic Disorders; D058826:Serotonin 5-HT2 Receptor Agonists; D013607:Tablets; D013810:Therapeutic Equivalency; D014508:Urea / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics
D014150:Antipsychotic Agents; D010880:Piperidines; D058826:Serotonin 5-HT2 Receptor Agonists; D013607:Tablets; D014508:Urea; C510793:pimavanserin